Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A.L. Appelt
Observed names:
A. Appelt,
A. L. Appelt,
Appelt, A.L.
Institutions:
Rigshospitalet,
Technical University of Denmark
Observed institutions:
The University of Sydney,
University of Leeds,
University of Southern Denmark,
St James's University Hospital,
Odense University Hospital,
Rigshospitalet,
University of Chieti-Pescara,
Vejle Sygehus,
Ospedale SS. Annunziata,
Technical University of Denmark
show all 10
OpenAlex ID:
A5069620489
PH-0162: Is there a radiation dose-response relationship for non-operative management of rectal cancer?
2020
·
A. Appelt
, A. Jakobsen
, et al.
·
Radiotherapy and Oncology
·
10
The dose-effect relationship in preoperative chemoradiation of locally advanced rectal cancer: Preliminary results of a phase III trial.
2011
·
A. K. M. Jakobsen
, A. L. Appelt
, et al.
·
Journal of Clinical Oncology
·
8
OC-0077: Towards individualized dose constraints: The QUANTEC radiation pneumonitis model with clinical risk factors
2013
·
A.L. Appelt
, S.M. Bentzen
, et al.
·
Radiotherapy and Oncology
·
2
PDF
PO-1638: Treatment delivery uncertainties in rectal cancer radiotherapy – evidence-based margin estimates
2020
·
A. Appelt
, M. Beasley
, et al.
·
Radiotherapy and Oncology
·
1
PV-0369: Tiredness, pain and quality of life for patients receiving RT for spinal cord compression
2018
·
M. Hemer
, V. Gram
, et al.
·
Radiotherapy and Oncology
·
1
PDF
PO-0745: Intrafractional movement of patients with spinal cord compression receiving radiation therapy
2017
·
E. Ravnkilde
, I.M. Jakobsen
, et al.
·
Radiotherapy and Oncology
·
1
PDF
OC-0542: Dysphagia, Odynophagia and Globulus in Patients Receiving RT for Spinal Cord Compression
2017
·
V. Gram
, M. Hemer
, et al.
·
Radiotherapy and Oncology
·
1
PDF
PO-1041: MRI-guided brachytherapy for rectal cancer: A treatment planning study with a shieldable multicatheter applicator
2014
·
A.L. Appelt
, B. Mortensen
, et al.
·
Radiotherapy and Oncology
·
1
ESTRO consensus recommendations: target volume and organ at risk delineation in rectal endoluminal high dose rate brachytherapy
2026
·
A.C. Valkenburg
, E.J. Van Limbergen
, et al.
·
Clinical and Translational Radiation Oncology
PDF
PO-1398 Long term urinary function after preoperative radio(chemo)therapy in locally advanced rectal cancer
2023
·
L. Riber
, A.L. Appelt
, et al.
·
Radiotherapy and Oncology
PO-1932 Rectal tumour position variation: Systematic and random variations by point-based surface evaluation
2023
·
D.T. Arp
, A.L. Appelt
, et al.
·
Radiotherapy and Oncology
SP-0708 What radiotherapy dose do we need to achieve clinical complete response in early and advanced tumours?
2021
·
A. Appelt
·
Radiotherapy and Oncology
PD-0846 Tumor match and adaptive radiotherapy reduce risk of radiation pneumonitis and increase survival
2021
·
D.S. Møller
, C.M. Lutz
, et al.
·
Radiotherapy and Oncology
PH-0606: AutoConfidence: Per-patient validation for clinical confidence in deep learning for radiotherapy
2020
·
M. Nix
, D. Bird
, et al.
·
Radiotherapy and Oncology
EP-1919 Voxel-based assessment of proton RBE in paediatric brain cancer radiotherapy from multimodal imaging
2019
·
M. Skaarup
, A. Appelt
, et al.
·
Radiotherapy and Oncology
SP-0445 The vital role of physicists in clinical trials: from design to data analysis
2019
·
A.L. Appelt
·
Radiotherapy and Oncology
PDF
EP-1352 Locally advanced NSCLC: performance status based eligibility for adjuvant check point inhibitor
2019
·
G. Persson
, T. Schytte
, et al.
·
Radiotherapy and Oncology
PDF
OC-0291: 3D image-guided treatment planning of Ru-106 brachytherapy for choroidal melanomas
2018
·
C.A. Espensen
, L. Fog
, et al.
·
Radiotherapy and Oncology
PDF
PO-0798: High dose IMRT for locally advanced rectal cancer – late toxicity and patient-reported outcomes
2018
·
A.L. Appelt
, B.M. Havelund
, et al.
·
Radiotherapy and Oncology
OC-0283: Prognostic value of serum NPY hypermethylation in neoadjuvant chemoradiotherapy for rectal cancer
2018
·
A.L. Appelt
, R.F. Andersen
, et al.
·
Radiotherapy and Oncology
PDF
PO-0754: Safe inhomogeneus RT dose escalation in locally advanced NSCLC, -interim results from NARLAL2
2018
·
T. Schytte
, T. Nielsen
, et al.
·
Radiotherapy and Oncology
PDF
PV-0474: Pelvic re-irradiation with Stereotactic Ablative Radiotherapy (SABR): outcomes and cumulative doses
2018
·
L. Murray
, R. Speight
, et al.
·
Radiotherapy and Oncology
PDF
SP-0232: Dose escalation for non-surgical management
2018
·
A.L. Appelt
·
Radiotherapy and Oncology
PDF
The prognostic impact of RAS and RAF serum mutations in localized colon cancer
2016
·
C.B. Thomsen
, A.L. Appelt
, et al.
·
Annals of Oncology
EP-1932: Quality assurance in implementing a national dose escalation trial in NSCLC – report from NARLAL2
2016
·
T.B. Nielsen
, C. Brink
, et al.
·
Radiotherapy and Oncology
PDF
Show more works
View as search
Works count:
29
Citation count:
25
H-index:
2
I10-index:
1
Year
Topic
Type